在重症慢性阻塞性肺病 (COPD) 恶化后康复期间的家庭高流疗法:混合方法可行性随机对照试验
Rebecca F D'Cruz1,2, Anne Rossel3,4, Georgios Kaltsakas3,2
1Lane Fox Clinical Respiratory Physiology Research Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK rebecca.dcruz@gstt.nhs.uk.
BMJ open respiratory research
|January 6, 2025
概括
这项研究发现,家庭高流量疗法 (HFT) 对COPD患者在恶化后可行. 它支持一项针对无入院生存的第三期试验,显示症状减少和清除改善.
科学领域:
- 肺部医学 肺部医学
- 呼吸系统护理 呼吸系统护理
- 临床试验 临床试验
背景情况:
- 慢性阻塞性肺病 (AECOPD) 的严重急性恶化导致30天高回收率 (20%).
- 从AECOPD中康复的Eucapnic患者是新型治疗干预措施的候选人.
- 在进行大规模试验之前,家庭疗法需要进行可行性评估.
研究的目的:
- 评估一项随机对照试验 (RCT) 在AECOPD康复中进行家庭高流量治疗 (HFT) 的可行性.
- 收集有关家庭高血压的临床,患者报告和生理结果的初步数据.
- 为未来第三阶段RCT的设计提供信息.
主要方法:
- 一个混合方法可行性RCT (ISRCTN15949009) 随机选择的非肥胖AECOPD患者接受常规护理或常规护理加家庭HFT.
- 收集的数据包括设备的使用,呼吸困难,生活质量 (CAT,CCQ),螺旋计和呼吸能力.
- 半结构面试探讨了患者在家中HFT的经验.
主要成果:
- 在45名符合条件的患者中,有18名患者被随机分类;超过90%的完整结局数据被收集,没有与设备相关的SAE.
- 每日HFT使用平均为每天2.3-2.7小时,在某些情况下为舒适性而进行修改.
- 较高的HFT使用与较低的症状负担相关 (CAT p=0.01),采访指出易于使用和减少药物需求.
结论:
- 家庭HFT是一种可行的干预措施,用于从AECOPD中康复的eucapnic患者.
- 可行性数据支持向第3阶段RCT进行进展,评估HFT对无入院生存的影响.
- 家庭HFT可以改善患者报告的结果,并减少恶化后的症状负担.
更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
177
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
177
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
171
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
171


